MENU

Movement Disorders

The Latest
More in Movement Disorders

Case Report

Case Report: Hemiparkinsonism in a Patient With Multiple Sclerosis

In this case, there was a causal relationship between comorbid diseases.

Andrea P. Lee, MD; Giulietta M. Riboldi, MD; Ilya Kister, MD; Jonathan E. Howard, MD; and Ritesh A. Ramdhani, MD

Columns

Hometown Highlights: Procedural Treatments for Movement Disorders

The Philadelphia Neurologic Society explores the journey from thalamotomy to MR-guided focused ultrasound for movement disorders.

Gordon H. Baltuch, MD, PhD

Guest Medical Editor's Page

The Importance of Sleep

Sleep has a critical role in brain health and is an essential part of improving neurologic care for all of our patients.

Logan Schneider, MD

Sleep & Neurodegenerative Disease

Sleep problems are common and treatable in neurodegenerative disorders, and may also be a treatable risk factor and early biomarker.

Raman K. Malhotra, MD

Movement Disorders Moment: Rapid Eye Movement Sleep Behavior Disorder

This sleep disorder is a strong predictor for the development of synucleinopathies, including Parkinson's disease, multiple system atrophy, and dementia with Lewy bodies.

Ahmad Alsibai, MD; and Jill M. Giordano Farmer, DO

Special Report

2018 Drug and Device Approvals for Neurology

Spotlight Topic: Neuropsychiatry

Cognitive Complaints and Neuropsychologic Testing

When should neuropsychologic tests be ordered and what questions should testing answer?

Nabil Ali, MD; Laura M. Clark, PhD, ABPP; and Kendra Corning, PsyD, HSPP

Healthy Cognitive Aging

There are evidence-based tools for staying sharp throughout the lifespan.

Brian K. Lebowitz, PhD, ABPP-CN; Elizabeth Londen, PhD; and Thomas Preston, PhD, ABPP-CN

Cover Focus: Technology & Wellness

Treating Stress to Improve Neurologic Outcomes

Research on the interaction between hormones and seizures supports the importance of helping patients manage stress.

Riley Bove, MD, MMSc; and Graham R. Huesmann, MD, PhD

Guest Medical Editor's Page

Wellness and Neurology

There is clear evidence for promoting wellness practices to all patients with neurologic disorders.

Patricia K. Coyle, MD, FAAN, FANA

Movement Disorders Moment: Shining a Light on the Off Periods of Parkinson's Disease

New formulations for rescue from the off period are coming.

Jill M. Giordano Farmer, DO; and Jeffrey Lahrmann, MD

Columns

Hometown Highlights: Introducing Hometown Highlights

In this new column, we feature content from presenters at the 2018-2019 Philadelphia Neurological Society meetings.

Stephen M. Gollomp, MD

Neurologists Wanted!

A recently graduated resident and new professor recommends ways to attract medical students to the specialty of neurology.

Rachel Gottlieb-Smith, MD

Anti-Alpha-Synuclein Therapies in Parkinson's Disease

Could therapies developed to stop cancers be the next breakthrough for neurodegenerative disorders?

Laxman B. Bahroo, DO; Mazen T. Elkurd, DO; Charbel E.-H. Moussa, MD, PhD; Fernando L. Pagan, MD; and Yasar Torres-Yaghi, MD

Seeking Breakthroughs: The Physician Perspective

A roundtable discussion with Claudia A. Chiriboga, MD, MPH; Jeffrey L. Cummings, MD, ScD; and Nir Lipsman, MD, PhD

Claudia A. Chiriboga, MD, MPH; Jeffrey L. Cummings, MD, ScD; and Nir Lipsman, MD, PhD


Seeking Breakthroughs: The Startup Perspective

A roundtable discussion with Chase Spurlock, PhD, IQuity; Michal Izrael, PhD, Kadimastem Ltd; Kevin Hrusovsky, Quanterix; and J. Michael Ryan, MD, Rodin Therapeutics

Seeking Breakthrough Treatments

Seeking Breakthroughs: The Industry Perspective

A roundtable discussion with Gregory Went, PhD, Adamas Pharmaceuticals; Lynn Kramer, MD, Eisai; Paulo Fontoura, MD, PhD, Genentech/Roche; Justin Gover, BSc, MBA, GW Pharmaceuticals; Marc Kamin, MD, SK Life Sciences; and Mike Davis, BSc, MBA, UCB

Guest Medical Editor's Page

Seeking Breakthroughs—We Want You!

The challenges we must overcome to find breakthrough treatments in neurology are many and the potential is great.

Shamik Bhattycharyya, MD, MS

Medical Marijuana and Parkinson's Disease

Given limited treatments available, investigating potential benefits of cannabinoids can offer cautious optimism over controversy.

Christina R. Maxwell, PhD, MTR; and Jill Farmer, DO, MPH

Pharmaceutical Treatment of Parkinson's Disease

The best outcomes rely on a handful of medicines and partnership among clinicians, patients, and caregivers.

Laura Buyan-Dent, MD; Teresa Mangin, MD; and Kathleen M. Shannon, MD

Show More